| Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha Antagonist (NCT01197755) | AstraZeneca | 2010-09-01 |
| A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA) (NCT01163747) | Genentech, Inc. | 2010-09-01 |
| Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis (NCT01282528) | Peking Union Medical College Hospital | 2010-09-01 |
| A Retrospective, Observational Study of RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (NCT01921478) | Hoffmann-La Roche | 2010-08-01 |
| An Observational Study of RoActemra/Actemra (Tocilizumab) in Smoking Versus Non-Smoking Patients With Rheumatoid Arthritis (NCT01337388) | Hoffmann-La Roche | 2010-08-01 |
| The Genetic and the Functional Study of DNA Repair System and the Susceptibility to Rheumatoid Arthritis (NCT01285336) | China Medical University Hospital | 2010-08-01 |
| Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA) (NCT01181050) | Janssen Research & Development, LLC | 2010-08-01 |
| A Study To Compare The Amount Of Tasocitinib (CP-690,550) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Three Different Tablet Versions Of Tasocitinib (CP-690,550) (NCT01184092) | Pfizer | 2010-08-01 |
| Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic Disorder (NCT01176682) | AstraZeneca | 2010-08-01 |
| An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis (NCT01283399) | Hoffmann-La Roche | 2010-08-01 |
| Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis (NCT01244958) | Frank Behrens | 2010-08-01 |
| A Study of Tocilizumab in Patients With Rheumatoid Arthritis (NCT01187563) | Regeneron Pharmaceuticals | 2010-08-01 |
| Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis (NCT01156155) | University of Nebraska | 2010-07-14 |
| Study of the Tolerability of Different SAR153191 Drug Products, That Differ With Respect to Manufacturing Processes and Formulation, at Different Concentrations and Doses in Healthy Male Subjects (NCT06159452) | Sanofi | 2010-07-09 |
| Analysis of Respiratory Mechanics in Patients With Rheumatoid Arthritis (NCT01641705) | Hospital Universitario Pedro Ernesto | 2010-07-01 |
| An Observational Study of Dosage Patterns in Routine Clinical Practice in Patients With Rheumatoid Arthritis (ACT-LIFE) (NCT01338545) | Hoffmann-La Roche | 2010-07-01 |
| Health Outcomes in Rheumatoid Arthritis in Greece (NCT01001182) | Pfizer | 2010-07-01 |
| An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB) (NCT01309282) | Hoffmann-La Roche | 2010-07-01 |
| Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia (NCT01147341) | Michael Schiff, MD | 2010-07-01 |
| Exceed ABT Acetabular Cup Cementless System (NCT04255394) | Zimmer Biomet | 2010-07-01 |
| Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain (NCT01351805) | Brigham and Women's Hospital | 2010-07-01 |
| Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) (NCT01146652) | Sanofi | 2010-06-21 |
| Safety and Efficacy of AMG 827 in Subjects With RA (NCT01059448) | Amgen | 2010-06-03 |
| Complement Regulatory Proteins Expression and Clinical Response in Rheumatoid Arthritis (RA) Patients Treated With Rituximab (NCT01096069) | Hospital de Clinicas de Porto Alegre | 2010-06-01 |
| Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients (NCT01633346) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2010-06-01 |
| Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics (NCT01166620) | Bristol-Myers Squibb | 2010-06-01 |
| Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis (NCT01132118) | Brigham and Women's Hospital | 2010-06-01 |
| Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis (NCT01143337) | Tanabe Pharma Corporation | 2010-06-01 |
| The Predictive Value of Ultrasound in Early Rheumatoid Arthritis (NCT01752309) | Erasmus Medical Center | 2010-06-01 |
| A Study in Rheumatoid Arthritis (NCT01253265) | Eli Lilly and Company | 2010-05-01 |
| A Study of Japanese Rheumatoid Arthritis Participants (NCT01253291) | Eli Lilly and Company | 2010-05-01 |
| TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs (NCT01131910) | Sormland County Council, Sweden | 2010-05-01 |
| An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis (NCT01277328) | Hoffmann-La Roche | 2010-05-01 |
| The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients (NCT01163617) | AbbVie (prior sponsor, Abbott) | 2010-05-01 |
| The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment (CARAT) (NCT01250548) | Baylor Research Institute | 2010-05-01 |
| Safety, Pharmacokinetic (PK), Pharmcodynamic (PD), and Drug-Drug Interaction of PLX3397 in Patients With Rheumatoid Arthritis Who Are Receiving Methotrexate (NCT01090570) | Plexxikon | 2010-05-01 |
| Study of the Response and Cardiorespiratory Endurance in Early RA Patients Treated With Tocilizumab or Methotrexate (NCT01245452) | Patrick Durez | 2010-05-01 |
| Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls (NCT01228812) | University of Lausanne | 2010-04-01 |
| Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy (NCT01021735) | University of Glasgow | 2010-04-01 |
| T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade (NCT01060098) | Imperial College London | 2010-04-01 |
| The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary Study (NCT01050010) | Centre Hospitalier Universitaire de Nice | 2010-04-01 |
| Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA) (NCT01067430) | Northumbria Healthcare NHS Foundation Trust | 2010-04-01 |
| A Study of Efficacy of Rituximab [Mabthera/Rituxan] in Patients With Rheumatoid Arthritis Using Magnetic Resonance Imaging of the Hand (RESONAR) (NCT01117129) | Hoffmann-La Roche | 2010-04-01 |
| Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid Arthritis (NCT01105715) | University of Arkansas | 2010-04-01 |
| Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases (NCT01151644) | University of Sao Paulo | 2010-04-01 |
| Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids (NCT01287533) | Yeong-Wook Song | 2010-04-01 |
| Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis (NCT01197066) | Korea Otsuka Pharmaceutical Co., Ltd. | 2010-03-01 |
| Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients (NCT01061736) | Sanofi | 2010-03-01 |
| A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs (NCT01034397) | Hoffmann-La Roche | 2010-03-01 |
| A Study of RoActemra/Actemra (Tocilizumab) in Adult Patients With Rheumatoid Arthritis (SVOBODA Programme) (NCT02010216) | Hoffmann-La Roche | 2010-03-01 |
| Association of Fear of Falling and Physical Activity in Rheumatoid Arthritis Comparison Before and After Biological Therapy (NCT01071863) | Newcastle-upon-Tyne Hospitals NHS Trust | 2010-03-01 |
| A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION) (NCT01610791) | Hoffmann-La Roche | 2010-03-01 |
| To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis (NCT01256736) | JW Pharmaceutical | 2010-03-01 |
| Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467)) (NCT01163292) | AbbVie (prior sponsor, Abbott) | 2010-03-01 |
| A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE) (NCT01063062) | Hoffmann-La Roche | 2010-02-28 |
| TL011 in Severe, Active Rheumatoid Arthritis Patients (NCT01123070) | Teva Pharmaceutical Industries, Ltd. | 2010-02-05 |
| Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis (NCT01111357) | University Hospital Center of Martinique | 2010-02-01 |
| An Electronic Data Capture Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement (NCT01134445) | DePuy International | 2010-02-01 |
| A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis (NCT01052194) | Vertex Pharmaceuticals Incorporated | 2010-02-01 |
| Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey (NCT01144598) | Abbott | 2010-02-01 |
| An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis (NCT00941707) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-02-01 |
| Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550 (NCT01059864) | Pfizer | 2010-02-01 |
| An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNF Therapy (REPEAT) (NCT01196780) | Hoffmann-La Roche | 2010-02-01 |
| Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis (NCT01038674) | Novo Nordisk A/S | 2010-02-01 |
| Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository (NCT01070121) | University of Alabama at Birmingham | 2010-02-01 |
| A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid Arthritis (NCT01754805) | Astellas Pharma Inc | 2010-01-22 |
| Avenir Müller Hip Stem Post Market Surveillance Study (NCT04079127) | Zimmer Biomet | 2010-01-09 |
| A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid Arthritis (NCT01050998) | MedImmune LLC | 2010-01-05 |
| An Observational Study of the Impact of RoActemra/Actemra on Fatigue in Patients With Rheumatoid Arthritis (PEPS) (NCT01185522) | Hoffmann-La Roche | 2010-01-01 |
| Use of Thermal and 3D Imaging to Quantify Arthritis (NCT01044823) | University of Pittsburgh | 2010-01-01 |
| A Randomised Trial Comparing Anterior Versus Posterior Approach in Total Hip Replacement (NCT01106560) | Medacta International SA | 2010-01-01 |
| Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS) (NCT02731560) | Prof. Abid Z. Farooqi | 2010-01-01 |
| Dose Escalation With Remicade® and Orencia® (NCT01141413) | Bristol-Myers Squibb | 2010-01-01 |
| Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction (NCT03382665) | Zimmer Biomet | 2010-01-01 |
| Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis (NCT00995449) | Humanigen, Inc. | 2010-01-01 |
| Local Analgesia in Knee- and Hipatroplastic Surgery in Patients With Rheumatic Disease: Extra- vs. Intracapsulare Position of Catheter (NCT01050738) | Spenshult Hospital | 2010-01-01 |
| Curcumin in Rheumatoid Arthritis (NCT00752154) | University of California, Los Angeles | 2010-01-01 |
| Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA) (NCT01198509) | NYU Langone Health | 2010-01-01 |
| A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid Arthritis (NCT01034137) | Hoffmann-La Roche | 2010-01-01 |
| An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid Arthritis (NCT01071798) | Hoffmann-La Roche | 2010-01-01 |
| Efficacy Study of Dextromethorphan to Treat Rheumatoid Arthritis (NCT02368093) | Taichung Veterans General Hospital | 2010-01-01 |
| Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate (NCT00950989) | Amgen | 2009-12-30 |
| Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis (NCT01000441) | University Hospital, Strasbourg, France | 2009-12-23 |
| Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis (NCT01163318) | AbbVie (prior sponsor, Abbott) | 2009-12-01 |
| Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid Arthritis (NCT01027728) | Amgen | 2009-12-01 |
| Total Knee Arthroplasty (TKA) Cemented Versus Cementless Tibial Prosthesis Study (NCT01041937) | Washington University School of Medicine | 2009-12-01 |
| Predictors of Adherence to Orencia (NCT01136707) | Bristol-Myers Squibb | 2009-12-01 |
| Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients (NCT01001832) | Bristol-Myers Squibb | 2009-12-01 |
| Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa Antagonists (NCT01040715) | Neovacs | 2009-12-01 |
| Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers (NCT01029613) | Glostrup University Hospital, Copenhagen | 2009-12-01 |
| Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis (NCT01023256) | MorphoSys AG | 2009-12-01 |
| SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (NCT01010581) | 4SC AG | 2009-11-01 |
| Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy (NCT00844714) | University of California, San Francisco | 2009-11-01 |
| A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis (NCT00976599) | Pfizer | 2009-11-01 |
| Effect of Patient Cost Sharing on Treatment Discontinuation Among Rheumatoid Arthritis Patients (NCT01137851) | Bristol-Myers Squibb | 2009-11-01 |
| 2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use (NCT01284283) | Encore Medical, L.P. | 2009-11-01 |
| Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants (NCT01009879) | University of Pittsburgh | 2009-11-01 |
| Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid Arthritis (NCT01007175) | Ablynx, a Sanofi company | 2009-11-01 |
| A Study of Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT00951275) | Hoffmann-La Roche | 2009-10-31 |
| A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs. (NCT00996203) | Hoffmann-La Roche | 2009-10-31 |